Chargement en cours...
Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
An efficient method to identify whether mild cognitive impairment (MCI) has progressed to Alzheimer’s disease (AD) will be beneficial to patient care. Previous studies have shown that magnetic resonance imaging (MRI) has enabled the assessment of AD progression based on imaging findings. The present...
Enregistré dans:
| Publié dans: | Front Neurosci |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7968420/ https://ncbi.nlm.nih.gov/pubmed/33746695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2021.584641 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|